RxE2 Direct-to-Patient IP Dispensing for a Dose-Ranging Phase 1/2 Decentralized Clinical Trial
Introduction In an innovative approach to improve clinical trial outcomes, RxE2 pioneered the integration of pharmacy practices into clinical trial workflows. This case study examines our collaboration with a large Contract Research Organization (CRO) working on behalf of a mid-sized pharmaceutical company, facing the challenge of executing a cost-effective, direct-to-patient solution for a complex Phase…